Cargando…
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
Tumor stem cells play a pivotal role in carcinogenesis and metastatic spread in colorectal cancer (CRC). Olfactomedin 4 (OLFM4) is co‐expressed with the established stem cell marker leucine‐rich repeat‐containing G protein‐coupled receptor 5 at the bottom of intestinal crypts and has been suggested...
Autores principales: | Jaitner, Stefanie, Pretzsch, Elise, Neumann, Jens, Schäffauer, Achim, Schiemann, Matthias, Angele, Martin, Kumbrink, Jörg, Schwitalla, Sarah, Greten, Florian R, Brandl, Lydia, Klauschen, Frederick, Horst, David, Kirchner, Thomas, Jung, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732686/ https://www.ncbi.nlm.nih.gov/pubmed/36349502 http://dx.doi.org/10.1002/cjp2.300 |
Ejemplares similares
-
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer
por: Elmasry, Manal, et al.
Publicado: (2019) -
The association of immunosurveillance and distant metastases in colorectal cancer
por: Jacob, Sven, et al.
Publicado: (2021) -
Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
por: Ye, Liangtao, et al.
Publicado: (2020) -
Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis
por: Jacob, Sven, et al.
Publicado: (2021) -
p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
por: Kumbrink, Jörg, et al.
Publicado: (2021)